Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01742286
Title Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: child
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | AUS

Facility Status City State Zip Country Details
Dana Farber Cancer Institute Dept of Onc Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering SC - 7 New York New York 10017 United States Details
Cincinnati Children s Hospital Medical Center Dept of Oncology Cincinnati Ohio 45229-3039 United States Details
St Jude s Childrens Research Hospital Dept of Oncology Memphis Tennessee 38105-2794 United States Details
Texas Children's Hospital Dept of Oncology Houston Texas 77030 United States Details
Novartis Investigative Site Randwick New South Wales 2130 Australia Details
Novartis Investigative Site Parkville Victoria 3052 Australia Details
Novartis Investigative Site Toronto Ontario M5G 1X8 Canada Details
Novartis Investigative Site Paris 75231 France Details
Novartis Investigative Site Villejuif Cedex 94805 France Details
Novartis Investigative Site Koeln Nordrhein-Westfalen 50937 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Utrecht CS 3584 Netherlands Details
Novartis Investigative Site Amsterdam 1105 AZ Netherlands Details
Novartis Investigative Site Rotterdam 3015 CN Netherlands Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46026 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site West Midlands Birmingham B4 6NH United Kingdom Details
Novartis Investigative Site Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field